Practical Oncologist Family of Sites
- 2014-07-30 - LGMC conducting research study on non-Hodgkin's lymphoma
- 2014-07-28 - U.S. Food and Drug Administration Approves Gilead’s Zydelig® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma
- 2014-07-22 - Celator(R) Pharmaceuticals Provides Update on CPX-351 and Technology Platform at Analyst Day
- 2014-07-22 - IDH2 Inhibitor Shows Promise in AML
- 2014-07-14 - FDA Approves Drug for Non-Hodgkin Lymphoma
- 2014-07-10 - FDA Approves Belinostat for Rare Lymphoma
- 2014-07-10 - Eagle Pharma gets US FDA tentative nod for patented, ready-to-dilute bendamustine HCl injection
- 2014-07-10 - University of Pennsylvania's Personalized Cellular Therapy for Leukemia Receives FDA's Breakthrough Therapy Designation
- 2014-07-03 - Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE® Antibody Blinatumomab In Acute Lymphoblastic Leukemia
- 2014-07-03 - Neutropenia Pathway Helps Patients Get Appropriate Therapy Sooner
- 2014-07-03 - Novel Epigenetic Therapy Shows Clinical Activity in Hematologic Malignancies
- 2014-07-03 - Pet therapy can make a difference in recovery
- 2014-07-03 - BCR-ABL Cutoffs at 3 Months Could Influence CML Treatment
- 2014-06-23 - Post-Induction PET Predicts Survival in Follicular Lymphoma
- 2014-06-23 - Leukemia Drug Stimulates Immunity Against Many Cancer Types